| |
| |
|
| Insider
Information: |
Malin Life Sciences Holdings Ltd |
| Relationship: |
10% Owner |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
11,835,673 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$33,968,382 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
11,835,673 |
|
|
| Total
Value |
$33,968,382 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poseida Therapeutics, Inc. |
PSTX |
10% Owner |
2022-08-08 |
11,835,673 |
2021-11-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PSTX |
Poseida Therapeutics, Inc... |
10% Owner |
– – • |
2022-08-08 |
4 |
B |
$3.50 |
$7,525,000 |
D/D |
2,150,000 |
11,835,673 |
2.45 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-12-06 |
4 |
B |
$6.90 |
$12,613 |
D/D |
1,828 |
9,685,673 |
2.37 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-12-02 |
4 |
B |
$6.88 |
$29,550 |
D/D |
4,296 |
9,683,845 |
2.37 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-12-01 |
4 |
B |
$6.85 |
$125,806 |
D/D |
18,365 |
9,679,549 |
2.45 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-11-30 |
4 |
B |
$6.85 |
$195,838 |
D/D |
28,592 |
9,661,184 |
2.45 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-11-18 |
4 |
B |
$7.18 |
$511,685 |
D/D |
71,312 |
9,567,501 |
2.45 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-11-17 |
4 |
B |
$7.21 |
$2,021,821 |
D/D |
280,384 |
9,496,189 |
2.45 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Common director with Issuer |
– – • |
2021-11-16 |
4 |
B |
$7.17 |
$198,383 |
D/D |
27,680 |
9,215,805 |
2.45 |
% |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
